Sarcopenia Treatment Market Scope And Analysis

Sarcopenia Treatment Market Report Scope

Competitive Landscape and Key Companies:

Abbott Laboratories, Bayer AG, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc., Sanofi SA, Amway Corp, GSK Plc, and Makers Nutrition LLC are among the prominent companies in the sarcopenia treatment market. These companies focus on introducing new technologies, upgrading existing products, and expanding geographic reach to meet the growing consumer demand worldwide.  

• In October 2023, Metagenics LLC completed the acquisition of 100% shares of Amipro Advanced Development Products. For many years, Ampiro has been the exclusive distributor of Metagenics LLC’s products in South Africa. The acquisition has strengthened the company’s distribution network in the country, further allowing it to have direct distribution operations in all major EMEA countries.
• In September 2023, Biophytis received Food and Drug Administration (FDA) authorization to launch its SARA-31 study in the US. It is the first-ever phase 3 study in the sarcopenia treatment specialty.
• In September 2022, Abbott India Ltd, a subsidiary of Abbott Laboratories, launched Ensure with HMB, a new formulation. The Ensure with HMB was launched to provide dietary support to elderly population in Indian. The product is formulated with the special and exclusive ingredient β-hydroxy-β-methyl butyrate (HMB), which helps counteract muscle loss, and restore strength and energy.
• In March 2022, MusclePharm Corporation, a global provider of leading sports nutrition and lifestyle brands of nutritional supplements, expanded its portfolio with the addition of the ready-to-drink protein category as it launched its new whey protein drink.